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A novel artificial loop scaffold for the noncovalent constraint of
peptides
Tarikere L Gururaja1, Shanaiah Narasimhamurthy2, Donald G Payan1
and DC Anderson1
Background: Few examples exist of peptides of < 35 residues that form a
stable tertiary structure without disulfide bonds. A method for stabilization and
noncovalent constraint of relatively short peptides may allow the construction
and use of intracellular peptide libraries containing protein minidomains. 
Results: We have examined a novel method for the noncovalent constraint of
peptides by attaching the peptide EFLIVKS (single-letter amino acid code), which
forms dimers, to the amino and carboxyl termini of different peptide inserts. An 18
residue random coil taken from the inhibitor loop of barley chymotrypsin inhibitor 2
was inserted between the peptides to produce a 32-mer minidomain that is
attacked only slowly by elastase, has numerous slowly exchanging protons,
contains a high β-structure content and has a Tm above 37°C. A point mutation
disrupting the hydrophobic interior in both dimerizing peptides causes a loss of all
slowly exchanging protons and of secondary structure. Adding specific charged
residues to each terminus substantially increased the Tm, as did point mutants
designed to add interdimerizer ion pairs. Three flexible epitope tag inserts and a
nonamer insert do not appear to be folded in a stable structure by EFLIVKS. The
properties of two peptides selected for expression in HeLa cells suggest they do
form a stable tertiary structure.
Conclusions: Attaching short dimerizing peptides to both the amino and
carboxyl termini of several 18-mer peptides appears to create stable monomeric
tertiary structures. Mutations in the dimerizers can either destabilize or
significantly stabilize a standard 18-mer insert. Dimerizing peptides flanking
random insert sequences could be used as a strategy to generate
heterogeneous peptide libraries with both extended and folded members. 
Introduction
Cyclic or otherwise constrained peptides have many valu-
able features compared with their linear analogs, including
enhanced stability to proteolysis and a restricted confor-
mation space that can result in a higher binding affinity for
cognate binding proteins, because of a reduced entropic
cost of binding. These constrained peptides contained in
minimized proteins can be used as an intermediate step in
the design of agents blocking protein–protein interactions
and as the basis for the subsequent design of small mol-
ecules, which may be useful as drugs [1,2]. When the pep-
tides are expressed in cells, they may modulate signaling
pathways [3] and if the peptides are expressed in live
mammalian cells, using retroviral vectors, they may be
screened for defined changes in cellular phenotype. The
resulting functional peptides may provide a route for the
affinity isolation of their binding partners.
Unlike peptides in phage-display libraries, intracellular
peptides are subject to proteolysis and thus library
members should be constructed to be relatively inert to
cellular proteases. Although intracellular peptide catabo-
lism has not been well characterized, the ubiquitin–protea-
some system is known to be involved in the degradation of
short and long half-life proteins [4,5]. Further proteolysis,
involving aminopeptidases, can result in degradation of
peptides to amino acids [6]. In antigen presenting cells,
short linear peptides resulting from cytoplasmic proteoly-
sis can be removed to the endoplasmic reticulum by the
peptide transporters TAP1 and TAP2 [7].
Owing to the presence of endogenous reduced glu-
tathione in the 2–10 mM range [8,9] and the presence of
thioredoxin reductase [10], standard methods of constrain-
ing peptides such as disulfide bonds are unlikely to work
in the cytoplasm. Larger protein scaffolds such as thiore-
doxin [11] or green fluorescent protein (GFP; B. Peelle,
personal communication) [12] have been used for the
intracellular display of peptides, and intein-based chem-
istry might also be useful for such display [13]. A scaffold
for the display of expressed peptides that is relatively inert
to proteolysis and small enough to allow access to protein
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binding sites (such as active-site crevices) may be useful
for modifying the function of these proteins. If the scaf-
fold is also flexible enough to allow the overall structure of
the library member to be determined to a significant
degree by the random insert sequence, a greater variety of
structures could be generated. 
To examine methods for the noncovalent constraint of
peptides, and thus for creating a minidomain, we have
added a 7-mer dimerizing peptide, EFLIVKS (single-
letter amino acid code), to both the amino and carboxyl
termini of a variety of test peptides. This peptide is the
reversed sequence of the core dimerizing peptide of the
neuropeptide head activator [14], is an equally potent
dimerizer in solution with an apparent Kd at pH 7.5 of
2 µM, and appears to form dimers with β structure
(T.L.G., unpublished observations). The formation of
peptide dimers between the termini of an intermediate
peptide sequence might be expected to constrain this
sequence because of the high local concentration of the
dimerizer peptides tethered by the intervening sequence.
We also have examined several different insert sequences,
including an 18-mer sequence taken from the protease
contact loop of barley chymotrypsin inhibitor 2 (Ci2; [15]).
This 18-mer analog has been reported to act as a 390 pM
inhibitor of elastase [16] when constrained with a disulfide
bond. As the peptide constructs examined here are not
sufficiently soluble to obtain a nuclear magnetic resonance
(NMR) structure, we have used proteolytic susceptibility,
deuterium exchange kinetics observed by mass spectrom-
etry (MS), and circular dichroism (CD) to examine their
overall structure. These 32-mer minidomains are in the
size range of the smallest reported peptides that form
stable folded structures [17–21], and may have a unique
structural motif relative to the simple secondary structures
of other small protein domains. 
Here, we show that several of these designed constructs
with the Ci2 insert appear to adopt a stable tertiary struc-
ture, and two have Tm values above 50°C. We also show
that two EFLIVKS-constrained peptides, present after
three rounds of screening for taxol resistance in HeLa
cells (D.G.P., unpublished observations), have a defined
secondary structure and slowly exchanging protons, and
one has a Tm of 60°C. The results suggest one mecha-
nism for obtaining stable peptides expressed within live
mammalian cells.
Results
Proteolysis of EFLIVKS-constrained chymotrypsin inhibitor
2 loop peptides and analogs
To examine the elastolytic stability of dimerizer-con-
strained peptides and two controls, we chose an 18-mer
sequence derived from the inhibitory loop of Ci2. Both
the native inhibitor and a disulfide-constrained engi-
neered loop peptide have been reported to block elastase
with a 390 pM inhibition constant [16]. To test the elas-
tase inhibition by this disulfide-constrained loop peptide
and potential inhibition by different peptide dimerizer-
constrained versions of this inhibitor loop (peptides 3 and
4–6, see Table 1), we incubated the peptides with elastase
in the presence of a chromophoric substrate (Table 2). In
each case, we observed either weak or no inhibition of the
enzyme by the peptide constructs, including the disulfide-
cyclized peptide 2, which gave only 66% inhibition at a
10 µM concentration.
To see if the peptide dimerizers fused to the termini of
the Ci2 insert peptide 3a protected the peptide from elas-
tase, we incubated peptides 3–6 with 100 nM elastase for
2–3 hours at pH 7.8, 25°C. Each reaction mixture was then
separated and analyzed using high-performance liquid
chromatography (HPLC)–MS as shown in Figure 1. As a
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Table 1
Peptide sequences studied.
Peptide Sequence Peptide Sequence
1 CGTIVTMEYRIDRTRSFC 12 MGEFLIVKSG4DYKDDDDKG4EFLIVKSGPPP
2 cyclic CGTIVTMEYRIDRTRSFC 13 MGEFLIVKSG4YPYDVPDYASLG3EFLIVKSGP
3 EFLIVKSVGTIVTMEYRIDRTRSFVEFLIVKS 14 MGEFLIVKSGDFNHFGNYLLDRRFFIAFGEFLIVKLGPP
3a VGTIVTMEYRIDRTRSFV 15 MGEFLIVKSGHSSGIPVGVGWCWNSAGGGEFLIVKSGPP
4 EFLIVKSVGTIVTMEYRIDRTRSFVSKVILFE 16 MGEFLIVKSVGTIVTMEYRIDRTRSFVEFLIVKSGPP
5 SKVILFEVGTIVTMEYRIDRTRSFVEFLIVKS 17 MGEFLIVKSG3ERPQEWAMEGPRDGLG3EFLIVKSGPP
6 SKVILFEVGTIVTMEYRIDRTRSFVSKVILFE 18 KFLIVKSVGTIVTMEYRIDRTRSFVEFLIVES
7 EEFLIVKKSVGTIVTMEYRIDRTRSFVEEFLIVKKS 19 EFLIVESVGTIVTMEYRIDRTRSFVEFLIVES
8 K6G4EFLIVKSVGTIVTMEYRIDRTRSFVEFLIVKS 20 EKLKVKSVGTIVTMEYRIDRTRSFVEKLKVKS
9 EFLKVKSVGTIVTMEYRIDRTRSFVEFLKVKS 21 ESLSVKSVGTIVTMEYRIDRTRSFVESLSVKS
10 KFLIVKSVGTIVTMEYRIDRTRSFVKFLIVKS 22 K3GSGSEFLIVKSVGTIVTMEYRIDRTRSFVEFLIVKSGSGSK3
11 EFLIVKSSTKSIPPQSEFLIVKS 23 K6GSGSEFLIVKSVGTIVTMEYRIDRTRSFVEFLIVKSGSGSK6
All peptides are carboxy-terminal acids.
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control, the peptide CGTIVTMEYRIDRTRSFC was
examined either in its unconstrained dithiothreitol-
reduced form (1) or in its oxidized (cyclic) form (2).
Peptide 1 (Figure 1a) was highly susceptible to elastolysis,
giving around 11 different identifiable peptides (Table S1,
Supplementary material). The main cleavage was after
Tyr9 and additional cleavages were after Ile4, Val5, Thr6,
Met7, Thr14 and Phe17. The cyclic analog 2 (Figure 1b)
was cleaved more slowly than its linear analog, and after 3
hours was cleaved mainly after Tyr9 and also after Met7,
Thr14 and Phe17. The proteolysis of peptide 2 by elastase
provides clear evidence that it is a substrate, and the
partial inhibition of elastase at the levels used in the
LC/MS experiment will underestimate the proteolytic
susceptibility of this peptide compared to other peptides
which do not inhibit elastase. We have not done further
experiments to determine the cause of the weak elastase
inhibition of peptide 2, but the observed inhibition could
be due to product inhibition at higher levels of substrate.
The Ci2 loop 18-mer with EFLIVKS attached to each end
(3, Figure 1c) was not attacked to a significant degree by
elastase after three hours, with only a small amount of pro-
teolysis after Tyr16 initially observed. Most small peaks
were synthetic impurities present in the absence of added
elastase. After 24 hours, enough proteolysis occurred to
assign additional elastolytic sites in this construct after
Val5, Met14, Thr21, Phe27 and Ile29. Thus, cleavage
occurred at many of the same residues as in the linear and
cyclic peptides, but at a much reduced rate. Peptides 4–6
were also not significantly attacked by elastase after 2.5,
3.2 and 2.7 hours, respectively (data not shown).
The addition of peptide dimerizers to the ends of peptide
3a thus appears to constrain the Ci2 peptide in a fashion
that confers resistance to elastase.
Deuterium exchange and gel filtration experiments using
constrained loop peptides
Relative to surface-exposed residues, the amide backbone
protons of peptides and proteins will exchange more slowly
with deuterated water when they are buried in the interior
of a protein (and are inaccessible to water) or are involved
in stable hydrogen bonding (see [22,23] and references
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Table 2
Peptide inhibition of porcine pancreatic elastase.
Assay % inhibition n
50 nM elastase 0
+ 500 nM peptide 2 6.2 ± 1.2 5
+ 10 µM peptide 2 66.4 ± 16.3 6
+ 10 µM peptide 3 –4.3 ± 0.63 3
+ 10 µM peptide 4 7.0 ± 1.0 3
+ 10 µM peptide 5 2.4 ± 0.29 3
+ 10 µM peptide 6 –1.4 ± 0.14 3
+ 2 µM PMSF 100
Figure 1
Elastolysis of linear, cyclic and dimerizer-
constrained peptides, derived from barley Ci2,
after reverse-phase high-performance liquid
chromatography separation and detection
using mass spectrometry. Base peak
chromatograms of different test peptides
(5–10 µM) were recorded after incubation
with 100 nM elastase in pH 7.8 0.15 M Tris
buffer at 25°C. (a) Peptide 1, a linear version
of the Ci2 insert, gives numerous fragments
after a 2.9 h incubation with elastase. (b) The
disulfide-cyclized peptide 2 also gives several
major fragments after a 2.1 h incubation; the
reaction was stopped with
phenylmethanesulfonyl fluoride (PMSF) and
dithiolthreitol (DTT) was added before
chromatography, to reduce any disulfide
bonds. (c) Little proteolysis is observed for
peptide 3 after a 3 h incubation. Peptides 4–6
gave similar results to 3. 
(a)
(b)
(c)
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therein). Mass spectrometry has been used to examine the
hydrogen exchange properties of a variety of different pro-
teins (see [24,25] for recent examples) and the existence of
slowly exchanging protons has been used to infer the exis-
tence of tertiary structure [19]. Deuterium exchange
studies described here were carried out at pH 5 to allow
ready observation of the peptide mass spectra, as low levels
of the peptides were hard to detect at higher pH values.
The pH was not reduced because some of the constrained
loops do not appear to retain structure below pH 4.5, as
measured by CD. To examine the compactness of the
peptide dimerizer-constrained Ci2 loop peptide, the rate
and stoichiometry of deuterium incorporation upon dilu-
tion into D2O was obtained. 
The kinetics of deuterium exchange for protons in several
representative peptide constructs, peptides 3, 6 and 14,
are shown in Figure 2. For these peptides, a total of
67 Da, 66 Da and 63 Da were added to the time zero mass
upon complete proton exchange, respectively. In the fast
phase (less than an hour), 29, 31 and 46 protons
exchanged, respectively. The expected number of fast-
exchanging sidechain and terminal protons in each case is
33, 33 and 27, respectively. For each peptide, a number of
additional protons exchanged over a period of around
300 hours. Each curve was well described as a first-order
process. The derived amplitudes of these more slowly
exchanging protons were 16, 17 and 21 protons, with cor-
responding rate constants of 0.054, 0.041 and 0.0044 h–1,
respectively (Table 3). Exchangeable protons not
accounted for in these two phases, inferred from the
missing amplitude relative to the total number of
exchangeable protons, were presumed to exchange even
more slowly. These were 21, 18 and zero protons for the
three peptides in Figure 2. Both classes of slowly
exchanging protons exchange at a rate far slower than that
measured for surface-exposed protons, taken from nearest
neighbors identical to those found in EFLIVKS [26].
These control protons exchanged with deuterium with
rate constants in the range of 6–60 h–1 at pH 5, giving an
estimate of protection factors for the protons with an
observable exchange rate studied here in the range of
1.2 × 102–1.2 × 103 for 3 and 6, and 1.4 × 103–1.4 × 104 for
14. The remaining unexchanged protons presumably have
tenfold or larger protection factors. 
With the Ci2 18-mer insert, similar results were obtained
with a different dimerizer, EEFLIVKKS, attached to each
end of the insert. For peptide 7, 39 of the 70 protons
exchanged with deuterium within an hour, eight
exchanged with a rate constant of 0.15 h–1 and the remain-
ing 23 protons exchanged more slowly. The total of 31
slowly exchanging protons in this analog was somewhat
less than the 37 protons in 1, suggesting some changes in
structure between the two constructs. Thus, with the
same Ci2 insert, several dimerizer variants produced mini-
domains with slowly exchanging protons. Not all peptide
dimerizers have this property, however. For the peptide 8,
with K6–G4 fused to the amino terminus of the parent
peptide 3 to enhance solubility, all but ~5 protons
exchanged within an hour. This amino-terminal fusion
may thus destabilize the structure of this construct or at
least increase its mobility. 
Substitution of Ile4 in EFLIVKS previously has been
shown to disrupt dimerization of this peptide (T.L.G.,
unpublished observations). We therefore tested a point
mutation in each dimerizer (creating EFLKVKS) attached
to the Ci2 18-mer insert (9, Table 1) and examined the
effect of this mutation on the 18-mer insert structure by
deuterium exchange. If this mutation disrupted the struc-
ture, the number of slowly exchanging protons would be
diminished. When the exchange kinetics were examined,
all but one proton exchanged within an hour. When the
amino-terminal glutamate in EFLIVKS was mutated to
lysine (creating KFLIVKS) and both mutant dimerizers
were fused to the Ci2 insert in 10, all slow-exchanging
protons were also lost. 
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Figure 2
Kinetics of deuterium exchange for dimerizer-constrained peptides. The
fit to a first-order equation of the time-dependence of mass increase for
dimerizer-constrained peptides, after a tenfold dilution in D2O at pH 5,
is plotted after subtraction of rapidly exchanging protons from the net
mass gain. The mass increase was measured by mass spectrometry.
(a) Exchange kinetics for peptide 3, giving an exchange rate constant of
0.054 h–1. A total of 16 protons exchanged in this phase, and 21 more
at a rate too slow to measure. (b) Similar exchange kinetics were seen
for peptide 6, giving a rate constant of 0.041 h–1 and an amplitude of
17 protons; 18 protons exchanged at a significantly slower rate.
(c) Exchange of protons for deuterium in peptide 15, with a rate
constant of 0.0044 h–1; 21 protons exchanged in this phase, and there
were no additional protons exchanging at a slower rate.
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We also examined the effect of different insert sequences
on the exchange kinetics of the overall peptide when
EFLIVKS or its analogs were fused to both termini of
these inserts. One insert, STKSIPPQS, represented an
analog of the protease inhibitor cyclic CTKSIPPQC [27].
Peptide 11 (Table 3) had a total of 36 exchangeable
protons, 33 of which exchanged in an hour. Thus, this
peptide construct did not appear to have a stable tertiary
structure. A second insert, the flag epitope tag DYKD-
DDDK, was flanked by four glycines on each end to
increase its flexibility and to allow binding to anti-flag
antibodies. This was fused to MGEFLIVKS at the amino
terminus and EFLIVKSGPP at the carboxyl terminus.
This construct 12 had 36 exchangeable protons, 35 of
which exchanged within an hour. A similar construct 13
included the influenza hemagglutinin epitope tag YPYD-
VPDYASL flanked by four and three glycine residues at
its amino and carboxyl termini, respectively. All protons
were exchanged for deuterium within ~1 h. Thus, both a
shorter insert sequence and inserts flanked by multiple
glycines did not have slowly exchanging protons.
Two additional peptides, present after three rounds of
peptide library screening for peptides that confer resis-
tance to taxol (D.G.P., unpublished observations), were
examined. Peptide 14, with the insert GDFNHFGNYLL-
DRRFFIAFG and a slightly modified carboxy-terminal
dimerizer EFLIVKLGPP, had 21 slowly exchanging
protons with a rate constant tenfold slower than for the
other constructs with slowly exchanging protons. Peptide
15, with the insert GHSSGIPVGVGWCWNSAGGG, had
around four measurable slowly exchanging protons and
a further 17 protons exchanging at a rate too slow to
measure in this experiment.
Saturated solutions of several peptides with slowly
exchanging protons were examined by gel filtration at pH
7.3 for evidence of oligomerization. A standard curve was
constructed from 23 different peptides and small proteins
(see the Materials and methods section). Peptides 6, 7 and
18 exhibited single main peaks with apparent molecular
weights of 1600, 2540 and 2360 Da, respectively (data not
shown). There were no peaks at higher integral multiples
of these molecular weights. The expected molecular
weights were 3778, 4293 and 3778 Da, respectively. Thus,
these constructs appeared to elute as monomers as some-
what smaller peptides than their true molecular masses or
than peptides used to construct the standard curve.
Peptide 15, however, exhibited a main peak with an
apparent molecular mass of 2240 Da, and a significant
leading shoulder with an apparent mass of 4400 Da (data
not shown). It also elutes at an apparent molecular weight
below its expected molecular mass of 3957 Da, but
appears to form some dimer in a saturated solution at
pH 7.3 as the main peak and shoulder are different in their
apparent molecular masses by a factor of two.
Circular dichroism studies of peptide constructs
Because the peptides studied here are not adequately
soluble for NMR structure determination, we examined
their solution structure using CD. These measurements
are sensitive to the secondary structure of both peptides
and proteins, and have been extensively used for confor-
mational analysis [28–30]. Here, these measurements are
used to examine secondary structure formation, pH
dependence and stability, to compare the effects of differ-
ent dimerizers on insert structure, to examine the struc-
tural effects of mutations in the dimerizers, and to look at
the effects of different insert sequences on the overall
structure of dimerizer-constrained loops. When these
measurements are combined with measurements of
proteolytic susceptibility, deuterium exchange and the
results of conformational searches, they give information
on the overall structure and folding of the minidomains
examined here.
Peptide 11
The first insert examined was a nonamer, to test the effects
of EFLIVKS constraints on a relatively short peptide. The
CD spectrum was recorded between pH 3.5 and 8.5
(Figure 3a). A pH-dependent secondary structure was
observed. At pH values of 4.5 and above the CD spectrum
suggests the existence of some β structure, and the Tm at
225 nm is 39.6°C (data not shown). At pH 3.5, a strong
minimum at 201 nm was seen, near the expected
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Table 3
Deuterium exchange rates and amplitudes for different peptide
constructs.
Peptide Total Proton exchange Measured
exchangeable amplitudes* exchange rate
protons constant
3 66.5 ± 1.4 29.3 ± 1.5 fast
16 intermediate 0.054 h–1
21 slow
6 66 31 fast
17 intermediate 0.041 h–1
18 slow
7 70.3 39.4 fast
7.9 intermediate 0.15 h–1
23 slow
8 87.7 82.8 fast
9 71.6 70.1 fast
10 47.1 47.7
11 36.1 ± 1.9 32.6 ± 3.8 fast
12 35.9 34.8 fast
13 40.3 40.3 fast
14 62.7 45.7 ± 0.2 fast
20.6 intermediate 0.0044 h–1
15 58.6 37.2 ± 1.0 fast
4.2 intermediate
17.2 slow
*The fast amplitude is calculated for protons exchanging within ~1 h.
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minimum for a random coil [31] of 195–197 nm. This curve
is also similar in shape to that of a type 1 β turn observed in
a short peptide [32]. The protamine-like protein from
Spisula also has a similar spectrum but has been shown to
have tertiary structure [33]. As this CD spectrum was seen
with other peptide constructs that exhibit a transition from
this spectrum at lower pH values to other spectra stable at
higher pH values, as its assignment to a secondary struc-
ture appears ambiguous, and as 11 was soluble at ~1 mM at
pH 4, the structure of this peptide was examined using
NMR (details are in the Supplementary material section).
The temperature coefficients of all amide resonances were
found to be ≥0.004 ppm K–1 (data not shown), suggesting
that the backbone NH groups are exposed to the solvent
and are not involved in any intramolecular hydrogen-
bonding interactions. The fast 1H/2H exchange rate
observed for all backbone amide resonances provides
further evidence that the amide groups are not involved in
any intramolecular hydrogen bonding. The prevalence of
strong dαN(i, i+1) and weak dαN(i, i+1) nuclear Overhauser
effects (NOEs) and a continuous stretch of weak and
medium dβN(i, i+1) and dαβ(i, i+1) NOEs in the absence of any
observable dNN NOE interactions indicate that the back-
bone dihedral angles are predominantly in the unfolded
region of φ, ϕ space [34,35]. The JNH–CαH values are in the
range of 6.5–8.4 Hz for all residues except Ser7. This sug-
gests the existence of populations of unfolded nonhydro-
gen bonded conformations of comparable energy with
φ values exceeding the regular helical region [36]. Collec-
tively, the NMR data suggest that peptide 11 is unstruc-
tured in aqueous solution at low pH.
In contrast to the results at pH 3.5, at pH 4.5–8.5 a differ-
ent secondary structure was observed by CD. These CD
spectra had a much diminished band at 202 nm, indicating
a loss of random coil. They also had a slight positive band
at around 210–215 nm, and a negative band around
228–230 nm, indicating the presence of β turns [37].
Because at pH 5.0 this construct has three or fewer slowly
exchanging protons (Table 3), the peptide may be
unfolded or in a molten globule state (i.e. it has no stable
tertiary structure) but may have secondary structure con-
taining some β turns and significantly less random coil than
at pH 3.5. When observing the CD spectrum at 225 nm,
the structure present at pH 7.5 has a Tm of 39.6 ± 1°C (data
not shown). The wide transition range of ~25°C is consis-
tent with the lack of a simple two-state transition and
perhaps the presence of a molten globule [38].
Peptides 3 and 3a
The pH dependence of the CD spectrum of peptide 3 is
shown in Figure 3b. At pH 3.5, the CD spectrum has a
prominent trough around 200 nm indicative, in view of the
above NMR results, of the presence of random coil. Also,
it has a strong maximum around 210 nm and strong
minimum at 225–230 nm, which is consistent with signifi-
cant beta-turn content [37]. The spectra at pH 4.5–6.5 are
different from that at pH 3.5 but similar to each other,
with the trough around 200 nm diminished and the peak
near 210 nm enhanced. At these pH values, there thus
appears to be less random coil. At pH 7.5, the 200 nm
minimum decreases further and the peak at ~210 nm is
enhanced, suggesting a further change in structure from
pH 4.5–6.5. Thus this peptide shows more structural plas-
ticity than peptide 11, but both have more random coil at a
low pH than at higher pH values. Peptide 3 has a Tm of
39.9 ± 1.6°C when observed at 225 nm (Figure 3b, inset),
and appears to melt over a significantly broader range
(80°C) than peptide 11 (~40°C). Peptide 3, unlike peptide
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Figure 3
CD spectra of EFLIVKS-constrained peptides. (a) pH-dependence of
the spectrum of peptide 11. Spectra were collected at pH 3.5–8.5, as
labeled. The pH 3.5 spectrum shows a significant increase in random
coil. The spectra are consistent with a low-pH transition to a structure
that is stable at pH values at and above 4.5. (b) pH dependence of
peptide 3. The spectra were acquired at pH 3.5–7.5, as labeled. The
spectrum of the 18-mer insert peptide 3a, which is a random coil at
pH 7.5, is shown at the bottom. The spectra of 3 are consistent with a
low-pH transition to a structure that is more stable at pH values at and
above 4.5. Inset: thermal melting curve of 3, giving a Tm of 39.9°C.
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11, has around 37 slowly exchanging protons. The large
number of slowly exchanging protons combined with the
observation of significant secondary structure suggests
that this construct has some stable tertiary structure. The
very broad melting range and low Tm suggests that the
low-temperature structure could have features of a molten
globule. However, these data do not seem to fit the classic
definition of a molten globule, which would not have pre-
dicted the slowly exchanging protons. 
The CD spectrum of peptide 3a, VGTIVTMEYRIDRT-
RSFV, was run at pH 7.5 as a control (Figure 3b). The CD
spectrum shows a prominent negative band around
197 nm, consistent with a random-coil structure. 
EFLIVKS constructs with an amino-terminal MG and
carboxy-terminal GPP
For peptide expression in live cells, MG was added to the
amino terminus and GPP to the carboxyl terminus to
potentially block proteolysis by cellular carboxypeptidases
[39]. The effect of these sequence additions on peptide 3
(now peptide 16) at pH 7.5 is shown in Figure 4. The CD
spectrum of 16 is similar to that of 3, except that there is
no minimum around 200 nm and only small changes are
seen in the spectrum between pH 3.5 and 8.5 (data not
shown). Like 3, peptide 16 has a very broad transition
range of over 80°C and a similar Tm of 38.4°C when
observed at 225 nm. The amino-terminal addition of MG
and addition of GPP to 3 appears to stabilize the low-pH
structure and to change the higher-pH structures by elimi-
nating random coil, without significantly changing the
overall stability as measured by the Tm.
The CD spectra of a variety of other EFLIVKS-con-
strained peptide inserts, all with an amino-terminal MG
and carboxy-terminal GPP, were also compared at pH 7.5
(Figure 4). These additional inserts were tested to
compare the ability of EFLIVKS to help fold peptides dif-
ferent from the Ci2 insert. Peptide 13 contains an insert
consisting of the influenza hemagglutinin epitope tag with
glycine spacers, G4YPYDVPDYASLG3. The characteristic
double minima in the CD spectrum at 205–207 nm and
220–225 nm indicate the presence of α helix [31]. This
construct did not have slowly exchanging protons
(Table 3); thus, the CD spectrum may reflect the presence
of only secondary structure or mobile tertiary structure. 
Peptide 12 contains the flag epitope tag with glycine
spacers, G4DYKDDDDKG4, as an insert. The resulting
CD spectrum contains a single minimum at 202 nm and
another small minimum at ~220 nm (Figure 4). On the
basis of the similarity of this spectrum to that of peptide 3
at low pH, this peptide appears to contain a significant
percentage of random coil. The Tm at 200 nm is 27.9°C
(data not shown). As peptide 12 does not have slow
exchanging protons (Table 3), it does not appear to have a
stable tertiary structure. Peptide 17 contains an insert
including the IκB epitope G3ERPQEWAMEGPRDGLG3
with flanking glycine spacers. It gave a CD spectrum with
a prominent band at 202 nm (Figure 4), which was
observed at pH 3.5–8.5, and a Tm measured at 200 nm of
35.7°C (data not shown). This construct thus appears to be
a random coil at all pH values examined.
Charge modifications of the peptide dimerizer
The effects of mutations in, or short additions to, the
EFLIVKS sequence on the CD spectrum of the Ci2
peptide insert are shown in Figure 5. Peptide 7 has addi-
tional charges in both dimerizer regions, giving the
sequence EEFLIVKKS. The 202 nm minimum, attrib-
uted to random coil, is diminished relative to peptide 3,
and the construct, with a Tm measured at 225 nm of
54.2°C (inset), is significantly more stable than peptide 3.
The spectrum shown, obtained at pH 7.5, is similar to
spectra obtained from pH 3.5–8.5 (not shown), and the
220–225 nm minimum is indicative of β structure as with
peptide 3. As peptide 7 has 31 slow-exchanging protons
(Table 3), it appears to have a stable tertiary structure.
In peptide 18, single lysine and glutamate residues were
switched between dimerizers, giving KFLIVKS–
Ci2–insert–EFLIVES. This change was made to encour-
age additional interdimerizer ion pairing. The CD spec-
trum at pH 7.5 (Figure 5) is quite similar to that of
peptide 7, with no major negative peak around 202 nm at
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Figure 4
CD spectra of dimerizer-constrained peptides with different insert
sequences in the scaffold MGEFLIVKS–insert–EFLIVKSGPP. All
spectra were acquired at pH 7.5. The peptides and their inserts are
16, Ci2 18-mer, 13, influenza hemagglutinin epitope tag, 12, flag
epitope tag, and 17, IκB epitope tag. The spectra depend on the
sequence of the insert. Peptides 12 and 17, which have multiglycine
spacers on each side of the epitope, have a significant random coil
content. Peptide 13 has a significant α-helical content.
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any pH (not shown), and a Tm of 56.9°C (not shown).
Peptide 18 thus appears to be even more stable than
peptide 7. Both 7 and 18 have no low-pH random coil
structure (not shown). In peptide 19, the lysine residue of
each dimerizer was mutated to glutamate, giving
EFLIVES-Ci2 insert-EFLIVES. The CD spectrum of
this peptide at pH 7.5 is similar to the CD spectra of 3, 7
and 18, missing the minimum around 202 nm, indicative
of random coil content. The overall structure of the Ci2
construct thus appears to be maintained with several
charge substitutions or additions, and the changes in 7 and
18 significantly stabilize the 32-mer construct relative to
the original peptide 3. 
Modifications to the hydrophobic core of EFLIVKS
In a third set of dimerizer modifications, the hydrophobic
character of the dimerizer was changed. In peptide 20
both Phe2 and Ile4 in both EFLIVKS sequences were
mutated to lysine, giving a dimerizer sequence at each ter-
minus of the Ci2 insert of EKLKVKS. The CD spectrum
of this peptide at pH 7.5 (Figure 5) indicates a significant
increase in random-coil content relative to 3. In peptide
21, both Phe2 and Ile4 were mutated to serine instead of
lysine. At pH 7.5, this peptide also had a significant
increase in random-coil content. In peptide 9, only Ile4
was mutated to lysine in each dimerizer, giving
EFLKVKS as the dimerizing sequence on each side of the
Ci2 insert. The pH 7.5 CD spectrum of 9, shown in
Figure 5, also has a significant minimum at 202 nm indi-
cating a significant loss of structure. This peptide had at
most one or two slowly exchanging protons (Table 3), sug-
gesting that this single change in the hydrophobic core of
EFLIVKS is sufficient to disrupt the structure of the
entire peptide construct. 
Fusion of charged sequences to one or both dimerizers of
peptide 3
To examine the importance for the overall structure of an
intact amino and carboxyl terminus of peptide 3, and to
potentially improve the solubility of the construct, we
fused different sequences to one or both termini of this
peptide. Peptide 8, resulting from fusion of K6G4 to the
amino terminus of 3, had a pH 7.5 CD spectrum shown in
Figure 6 that is very different than that for peptide 3, with
a broad minimum at 220–225 nm. This spectrum does not
appear to be characteristic of any one dominant secondary
structure, and can be deconvoluted to a mixture of β sheet
and β turn (58%), α helix (14%) and 28% random coil. As
this structure has at most five slowly exchanging protons
(Table 3), the additional residues added to the amino ter-
minus appear to have destabilized the tertiary structure of
the control peptide, while creating a different secondary
structure. In peptide 22, fusion of K3GSGS to the amino
terminus and GSGSK3 to the carboxyl terminus of 3
resulted in the appearance of a broad minimum in the
pH 7.5 CD spectrum at 215–220 nm, which does not
appear to be characteristic of a single secondary structure.
In peptide 23, K6GSGS and GSGSK6 were fused to the
amino and carboxyl termini, respectively. The pH 7.5 CD
spectrum (Figure 6) is dominated by a minimum at
202 nm which is characteristic of a random coil structure.
This minimum dominates the spectrum at all pH values
between pH 3.5–8.5 (data not shown). Thus fusions of
7–10mer peptides containing multiple lysines to one or
both termini of 3, intended to help solubilize this struc-
ture, have instead caused either a major shift in, or loss of,
secondary structure, or a loss of tertiary structure com-
pared with peptide 3. 
Peptides expressed in mammalian cells
Two peptides present after three rounds of screening for
resistance to taxol treatment in HeLa cells (D.G.P.,
unpublished observations), 14 and 15, were also exam-
ined using CD. Both were poorly soluble, with saturated
solutions in pH 7.5 phosphate-buffered saline (PBS) con-
taining 59 and 4 µM, respectively, as measured by amino-
acid analysis. The CD spectrum of peptide 15 (Figure 7)
has a relatively pH-independent (not shown) broad
minimum around 215 nm and a Tm of 40.6°C when mea-
sured at 218 nm (Figure 7, inset). The transition range for
15 was the narrowest observed for any EFLIVKS-con-
strained peptide, covering around 20°C. This peptide has
a total of 21 slow exchanging protons and thus has a stable
tertiary structure. 
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Figure 5
CD spectra of peptides with mutations in, or short additions to, the
dimerizer sequence at pH 7.5. All peptides have the Ci2 18-mer insert
sequence between the two dimerizer sequences. Peptides 7, 18 and
19 all lack significant random-coil content and contain β structure.
Both 7 and 18 are significantly more stable than 3, with Tm values of
54.2°C (inset) and 56.9°C, respectively. The mutations in 9, 20 and
21, which disrupt the hydrophobic core of each dimerizer, all appear to
disrupt the structure of the overall construct, causing a significant
increase in random-coil content, as shown by the significant minimum
around 202 nm.
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The spectrum of peptide 14 is nearly identical to that of
15 in spite of a very difference insert sequence
(Table 1), with a pH-independent (not shown) broad
minimum at 215–220 nm (Figure 7). Unlike 15, it has a
thermal transition range of around 90°C, and a Tm of
60.0°C at 218 nm (Figure 7, inset). This is the most ther-
mostable EFLIVKS-based construct, with a Tm in the
range of many proteins. This construct also had 21
protons with a slow exchange rate (Table 3) and thus a
stable tertiary structure. 
Discussion
Here, we have examined the secondary and tertiary struc-
ture of a variety of 32-mer peptides folded by self-binding
peptides fused to their amino and carboxyl termini. As
the peptides were generally soluble at concentrations less
than 60 µM and at pH values where they were folded, a
direct determination of structure using NMR methods
would be difficult. We thus combined several different
methodologies to examine the existence of tertiary struc-
ture in these peptides. An insert of roughly 18 residues
may be needed for stability of the entire construct. When
a shorter nonamer insert is used (peptide 11), giving an
overall length of 23 residues, a defined secondary struc-
ture is obtained, but without slowly exchanging protons.
This peptide may thus be too short to form a stable ter-
tiary structure with the scaffold used here. The smallest
natural monomeric protein domains stable in the absence
of disulfide bonds or the binding of stabilizing cofactors
such as metal ions, are around 50–60 residues. In spite of
this, smaller stable domains have been designed or
reported, including a monomeric 23-mer peptide with a
zinc-finger-like fold [17,40], a stable 33-mer two-helix
analog of the Z-domain of protein A [18], a 35-mer
monomeric stable, folded subdomain of the headpiece
domain of villin [19], a stable ββα motif peptide [20], and
a stable 36-mer three-helical peptide analog derived from
dihydrolipoamide acetyltransferase [21]. The stable con-
structs reported here are thus in the size range of the
smallest protein domains.
The self-dimerizing peptide EFLIVKS, when fused to
the amino and carboxyl terminus of the Ci2 peptide 3a,
appears to fold the peptide into a stable structure at room
temperature. It has 37 slowly exchanging protons and sig-
nificant β-turn content, as measured by CD. The broad
melting range of this peptide observed by CD, coupled
with the observation of slow-exchanging protons, suggests
that this peptide construct may have more than one slowly
exchanging conformer. Although the Ci2 loop in the
context of barley chymotrypsin inhibitor is a potent elas-
tase inhibitor, the EFLIVKS-constrained Ci2 insert
(peptide 3) is not an elastase inhibitor and is quite inert to
elastolysis, and the cyclic peptide 2 is not a 390 pM
inhibitor as reported but is instead a substrate with weak
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Figure 6
CD spectra of peptides resulting from the fusion of different
sequences to one or both termini of peptide 3, collected at pH 7.5. In
peptide 8, K6G4 was fused to the amino terminus of 3; in peptide 22,
K3GSGS and GSGSK3 were fused to the amino and carboxyl termini,
respectively; in peptide 23, K6GSGS and GSGSK6 were fused to the
amino and carboxyl termini, respectively. The fusions cause a loss of
most slowly exchanging protons in 8, the appearance of a rather
different structure in 22 compared with 3, and the appearance of
random coil at all pH values tested in 23. 
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Figure 7
CD spectra of peptides previously expressed in mammalian cells. The
CD spectrum of peptides 14 and 15 are shown. Although these
peptides have 18-mer inserts with different sequences, both spectra
reflect the existence of β structure and are similar to each other.
Peptide 15 has a Tm of 40.6°C when observed at 218 nm (inset).
Unlike most other constructs, this peptide has a relatively narrow
transition range, around 25–50°C. Peptide 14 has a Tm of 60.0°C
(inset), a broad transition range, and is the most stable dimerizer-
constrained peptide examined.
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inhibition. Thus, the dimerizers appear to have created a
unique set of structures compared with the loop structure
present in barley chymotrypsin inhibitor and with the
disulfide-cyclized version of the peptide. 
One question is whether the Ci2 insert itself dominates
the folding of its constructs with different peptide dimer-
izers. The CD spectrum of the insert itself, peptide 3a,
appears to contain mainly random-coil structure. Three
constructs with variations in the peptide dimerizer, 3, 6
and 7, all have slowly exchanging protons and nonrandom-
coil CD spectra. However, specific mutants in the dimer-
izer, Ile4→Lys and Ile29→Lys, as well as a K6G4–
amino-terminal fusion, disrupt the structure of peptide 3,
driving it into a random coil. These data suggest that addi-
tion of the bare dimerizers to both termini plays a signifi-
cant role in the folding of this insert. 
Two modified dimerizers significantly stabilized the Ci2
insert relative to the EFLIVKS dimerizer. EEFLIVKKS
added to both termini of 3a, and a combination of
KFLIVKS at the amino terminus and EFLIVES at the
carboxyl terminus, increased the Tm of the Ci2 insert by
14.3 and 17.0°C relative to 3, and both constructs retained
their slowly exchanging protons. Given the sequence
changes in these improved dimerizers, the increase in sta-
bility could be due to additional ion pairs between the
two dimerizers. 
In the context of an amino-terminal MG and carboxy-ter-
minal GPP, the EFLIVKS dimerizer folds some but not
all insert sequences into stable tertiary structures. Peptide
16 has a structure with similar stability to 3 and with less
random coil, and peptides 15 and 14, with a slightly modi-
fied second dimerizer, form stable tertiary structures.
However, three epitope tag inserts flanked by multiple
glycine residues, either had no slowly exchanging protons
or had significant random-coil structure, as observed by
CD. This could be due to the flexible nature of the insert
sequence (containing eight and seven glycines, respec-
tively) and the expected charge repulsion-driven
extended structure of the flag sequence, which has five
aspartates in a seven-residue stretch. 
One possible concern about using peptides with high self-
affinity is intermolecular aggregation. In theory, the high
local concentration of dimerizing peptides, due to their
tethering together by the insert sequence, should result in
saturation of even moderate dimerizer self-binding con-
stants forming ‘intramolecular’ dimers, and a monomeric
constrained structure. This structure should predominate
over hetero-oligomers when the intramolecular (local) con-
centration of dimerizers is greater than the solution con-
centration. No dimers or higher-order structures of
peptide 3 were observed by MS (data not shown) or for
peptides 6, 7 and 18 by gel filtration in PBS.
To examine dimerizer-constrained peptides present after
intracellular screening in mammalian cells, we synthesized
and studied the structural features of peptides 14 and 15.
In 14, the combination of 21 slowly exchanging protons, a
Tm of 60°C with a broad melting transition, and a nearly
pH-independent CD spectrum with little random coil,
suggest that this peptide folds into a stable tertiary struc-
ture with multiple slowly exchanging, low-energy con-
formers. Human epidermal growth factor may use some
residues from a four-residue surface aromatic cluster for
receptor recognition [41], whereas a water-accessible
cluster of five aromatic residues may be involved in ligand
binding and receptor activation in the dopamine D2 recep-
tor [42]. The 35-residue miniprotein HP35 has a cluster of
three aromatic residues that pack together and may be
important for folding [19,43]. Thus, the insert sequence in
14, which has seven aromatic residues, may use these
residues for the peptide’s function, folding or stability. 
For peptide 15, the combination of 21 slowly exchanging
protons, a Tm of 40.6°C with a narrow melting transition,
and a nearly pH-independent CD spectrum with little
random coil, suggests formation of a stable tertiary struc-
ture with relatively few slowly exchanging, low-energy
conformers. Gel filtration experiments suggest the exis-
tence of some peptide dimer in a 59 µM solution at pH 7.3.
The narrower melting curve may also reflect dimerization
of this peptide. The insert in this peptide contains a repeat
pattern of tryptophan and valine alternating with less
hydrophobic residues, suggesting a run of β sheet that is
consistent with the CD spectrum. As β sheets are known to
aggregate, this short stretch may be involved in intermolec-
ular dimerization of this construct. Neither peptide 14 nor
15 is very soluble. Beside the formation of a stable tertiary
or quaternary structure, this limited solubility could be an
additional mechanism for surviving intracellular screening
and thus, presumably, for surviving cellular catabolism. 
As different 18-mer inserts between the two terminal
EFLIVKS peptides gave both folded and unfolded con-
structs, depending on the insert sequence, peptide
libraries based on this scaffold will probably be a mixture
of constrained and unconstrained peptides. A peptide
library could contain stable folded structures such as pep-
tides 14 or 15, peptides with secondary, but not tertiary,
structure such as 12 or 13, or peptides with no stable struc-
ture, such as 17. In view of the unfolding of peptide 3 by
the fusion of additional amino-terminal or both amino- and
carboxy-terminal sequences, libraries containing additional
fusion sequences with this scaffold may be more biased to
extended structures. The only short peptide insert tested,
a nonamer, gave an unfolded peptide, perhaps because the
overall length (23 residues) is too short to allow folding for
most peptide sequences. Thus, to give more stable
libraries, longer random inserts, such as 18-mers, appear to
be preferable for intracellular screens.
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Significance
Creating very small proteins without the disulfide bonds
used in nature to stabilize small domains, such as cono-
toxins, is a challenge to protein engineers. A method to
noncovalently constrain a small domain is important if
the goal is to express a library of very small proteins in
the cytosol of a cell for the purpose of intracellular
screening. Current approaches to the creation of very
small proteins include the careful construction of two or
three contiguous segments of secondary structure or the
inclusion of other constraints such as metal-ion binding
sites. Here we have described a novel method to create a
very small protein by attaching dimerizing peptides to the
amino and carboxyl terminus of the intervening
sequence. The overall structure is sensitive to changes in
the dimerizers. By mutating individual residues to create
potential ion pairs across the dimer interface, a construct
with a Tm as high as 57ºC has been created. After several
rounds of selection in a mammalian cell, two peptides
using this scaffold appeared to have a stable structure,
with Tm values of 41ºC and 60ºC. One has seven aro-
matic residues, suggesting that the random 18-mer insert
can allow additional selection for a stable structure. The
low solubility of these peptides, as well as their folding,
may allow them to escape intracellular proteolysis.
Although we have not determined the structure of these
constructs, the use of terminal dimerizers appears to
impart some unique structural elements to these mini-
domains.
Materials and methods
Synthesis and purification of peptides
Peptides were synthesized on a Symphony/ Multiplex peptide synthe-
sizer (Protein Technologies Inc., Tucson, AZ, USA) using standard
Fmoc (9-fluorenylmethyloxycarbonyl ) chemistry [44], and purified by
reversed-phase chromatography. Automated coupling methods and
standard synthesis protocols were insufficient for some peptides, as
outlined below. Since the sequences are enriched with β-branched
amino acids as well as hydrophobic residues, syntheses of these test
peptides were carried out in a semi-automated fashion after coupling
the first 11 amino acids in an automated mode. Coupling of amino
acids in general was carried out twice with a fivefold excess of Fmoc-
protected α-amino acid for 2 h in a mixture of dimethylformamide
(50%, [v/v]) and N-methyl pyrrolidone, using diisopropylcarbodiimide-
hydroxybenzotriazole mediated couplings [45]. To ensure completion
of the coupling reaction, an aliquot of the resin was tested using the
ninhydrin reaction [46]. Segments of the test peptides that posed diffi-
culty in completing either Fmoc-deprotection or coupling reaction
steps are shown for three representative peptides. The synthesis of
peptide 3 was performed on preloaded Fmoc-Ser(tBu)-Wang resin
(Advanced ChemTech, Louisville, KY, USA), while the syntheses of
peptides 14 and 15 used H-Pro-2-Cl-Trt-resin (Infinity Biotech,
Upland, PA, USA). Deprotection was achieved with two 20 min reac-
tions with 25% (v/v) piperidine in dimethyl formamide (DMF), except
as noted.
Peptide solubility
Peptides were dissolved in phosphate-buffered saline at pH 7.5 by
repeated sonication. The suspended solution was then centrifuged and
the supernatant removed. A 100 µl aliquot was sent to the Protein
Structure Lab at the University of California at Davis for amino acid
analysis. The number of moles of the soluble tested peptide were then
calculated from the known amino acid composition of the peptide.
Synthesis of dimerizer peptides
Peptide 3. Difficult coupling steps in peptide 3 are in italics, and the
reagents which were successfully used are listed below. EFLIVKSVG-
TIVTMEYRIDRTRSFVEFLIVKS. Coupling of R to T used 2-(1-H-benzo-
triazole-1-yl)1,1,3,3-tetramethyluroniumhexafluorophosphate (HBTU),
N-hydroxybenzotriazole (HOBt) and diisopropylethylamine [47]. Cou-
pling of R to I used the pentafluorophenyl active ester of fmoc-arg.
Coupling of V to T used O-(7-azabenzotriazole-1-yl)-1,1,3,3, tetram-
ethyluronium hexafluorophosphate (HATU), 1-hydroxy-7-azabenzotria-
zole (HOAt), diisopropylethylamine [48]. Coupling of I to V and L to I
utilized diisopropylcarbodiimide and HOBt at 55°C in 1:1:1
dichloromethane : dimethylformamide : N-methyl pyrrolidone with 1%
Triton X-100 and 2 M ethylene carbonate [49]. Deprotection of Fmoc
in the LIV sequence used two 20 min treatments with 2% 1, 8-diazabi-
cyclo[5, 4, 0] undec-7-ene (DBU) in DMF with 5% (v/v) piperidine [50]. 
Peptide 14. For this peptide, MGEFLIVKSGDFNHFGNYLLDRRFFIAF-
GEFLIVKLGPP, all of the italicized amino acids were triple-coupled in a
fivefold excess of the Fmoc-amino-acid using benzotriazole-1-yl-oxy-
tris-(dimethylamino)-phosphoniumhexafluorophosphate (BOP), [51] -
HOBt-diisopropylethylamine. The couplings of I to V and L to I (bold)
used a three-hours-per-coupling triple coupling with HATU-HOAt-
diisopropylethylamine [48]. Deprotections for the L to I and I to V cou-
plings were performed using two 20 min reactions with 2% DBU in
DMF containing 5% (v/v) piperidine [50]. 
Peptide 15. For this peptide, MGEFLIVKSGHSSGIPVGVGWCWN-
SAGGGEFLIVKSGPP, the italicized residues were triple-coupled as in
peptide 14 above. I to V and L to I couplings (bold) and deprotections
were as in peptide 14. 
Elastolysis of peptide constructs
Inhibition of elastase by synthetic peptides was measured with pep-
tides (10 µM or as indicated) incubated with 50 nM elastase for 1 min
followed by assay of the elastase at pH 7.88, 25°C, using 100 µM suc-
cinyl-Ala–Ala–Ala–p-nitroanilide as a substrate. The change in
absorbance at 412 nm with time was observed, and the initial slope
was calculated. Inhibition was calculated as:
1 – ([enzyme activity + peptide] – [enzyme activity + PMSF])/([enzyme
activity + no addition] – [enzyme activity + PMSF]). 
For examination of elastolysis by MS, purified synthetic peptides
(5–10 µM final concentrations) were dissolved in 0.15 M tris buffer,
pH 7.88, at 25°C. Elastase was added to 100 nM. At times of ~0,
15 min, and 1, 2, 3 and 24 h, an aliquot of the reaction mixture was
injected onto a 0.1 × 25 cm C18 reverse-phase HPLC column (Vydac
Inc., Hesperia, CA, USA) for peptides 1 and 2, or onto a 0.1 × 25 cm
betabasic cyano reversed-phase column (Keystone Scientific, Belle-
fonte, PA, USA) for peptides 3–6. For peptides 1 and 2, the reaction
mixture was eluted at 100 µl/min. using 100% A (99.88% H2O, 0.1%
[v/v] acetic acid, 0.02% trifluoroacetic acid) for 4 min, followed by a
1%/min increasing gradient of B (99.88% acetonitrile, 0.1% acetic
acid, 0.02% trifluoroacetic acid) to 40% B, and a 6%/min gradient of B
to 100%. For peptides 3–6, elution was with 10% B for 4 min followed
by a 1%/min gradient increasing in B for 60 min, and a 6.7%/min
increasing gradient in B for 6 min. Peptides were examined by direct
elution from the column into the electrospray source of a Finnigan LCQ
ion trap mass spectrometer. Peptide masses were scanned from
300—2000 amu, and identified by searching their mass with that of dif-
ferent fragments of the full-length peptide, or comparing their mass
with different masses of expected elastolytic fragments in the case of
the cyclic peptide, using MacBioSpec (obtained courtesy of PE-Sciex,
Foster City, CA, USA).
Proteolysis of the reduced peptide CGTIVTMEYRIDRTRSFC was
carried out in the presence of 2 mM DTT (Sigma Chemical Co.,
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St. Louis, MO, USA). Cleavage products of the oxidized peptide were
either directly chromatographed without reduction, or chromatographed
after an aliquot was treated first with 1 mM PMSF for 1 h and then with
30 mM DTT for 10 min. 
Gel filtration of peptides
Gel filtrations experiments to obtain the apparent molecular weight of
selected peptide constructs in saturated solutions were run on a
1 × 30 cm Pharmacia Superdex Peptide column equilibrated with Dul-
becco’s phosphate buffered saline (pH 7.3) (Mediatech Inc., Herndon,
VA, USA). Column elution was carried out using a Hewlett-Packard
1100 high-performance liquid chromatography instrument at
0.35 ml/min at 23°C. The apparent molecular weights of the constructs
were calculated from a standard curve containing eight proteins
ranging in molecular weights from 21.5–3.5 kDa and 16 peptides
ranging in molecular weights from 0.4–5 kDa. 
Deuterium exchange measurements
Deuterium exchange experiments were carried out by dissolving the
peptide of interest in water at pH 5, and diluting the peptide ten-fold
into D2O at t = 0. For the initial constructs tested, the peptide concen-
trations after dilution in D2O were in the range of 10 µM. For other time
points, an aliquot of the peptide solution was quenched by addition of
a 2.5-fold volume excess of 1:1 H2O : MeCN with 1% formic acid at
0°C or 25°C and immediately infused into the mass spectrometer. This
acidic pH jump slows the rate of amide-bond hydrogen exchange with
solvent. For selected time points, the mass derived from the first
two minutes of the infusion was compared with that of later 2 min
blocks to assess the significance of back-exchange, which was usually
one proton or less. The total number of exchangeable protons was
derived by (a) initially dissolving the peptide in DMSO, diluting it
directly into D2O before quenching, and measuring the new mass of
the peptide several minutes later; (b) diluting a peptide dissolved in 5%
dimethylsulfoxide (DMSO) tenfold into D2O; or (c) heating the solution
of peptide diluted into D2O at 100°C for 15 min. DMSO was included
since, in preliminary experiments, low levels added to aqueous pep-
tides appeared to greatly accelerate proton exchange. When all three
methods were used with peptide 3 they gave the same results. Calcu-
lation of the total protons exchanged included correction for the 10%
by volume of H2O present after dilution in D2O. For peptides which
were soluble in the 1 mM range, samples from the tenfold D2O solution
at pH 5 were directly infused into the mass spectrometer without
quenching. Rate constants and amplitudes for deuterium exchange
were derived by fitting the timecourse of the gain in mass above the
fully protonated form to a single exponential function.
Circular dichroism measurements
Circular dichroisin spectra were recorded on an AVIV 62A DS CD
spectropolarimeter (Lakewood, NJ, USA) equipped with a Peltier cooler.
The temperature of the instrument was maintained constantly below
20°C using a Neslab CFT-33 refrigerated recirculator waterbath. The
instrument was periodically calibrated with the ammonium salt of (+)-10-
camphorsulfonic acid, according to the manufacturer’s recommenda-
tions. Spectra were recorded between 250 and 195 nm at 0.2 nm
intervals with a time constant of 1 s at 25°C. Data were collected from
five separate scans and averaged using an IBM PS/2 computer . A rec-
tangular quartz cell of path length 0.1 cm was used for the spectral
range with the peptide concentration in the range of 0.02–0.05 mM as
determined by amino acid analysis. Peptide stock solutions (up to
1 mM) were made in 10 mM KPO4 buffer containing 100 mM KF at
pH 7.5, and were diluted in the same buffer to the final concentration.
For pH titration experiments, the pH of the buffer was carefully adjusted
to the desired value using either 0.1 M HCl or 0.1 M NaOH, before
adding the above peptide stock solution. Raw data were converted to
ASCII format and plotted using Microsoft Excel [52]. Thermal denatura-
tion data were acquired on samples containing 20 µM peptide in 10 mM
KPO4 buffer containing 100 mM KF at pH 7.5. The thermal denaturation
was measured at the appropriate wavelength over a range of 4–98°C,
with a temperature step of 2°C, a 2 min equilibration time and a 60 s
signal averaging time. The data were fitted to a logistic sigmoid equation
using the Levenberg-Marquardt algorithm in Ultrafit (Biosoft, Cambridge,
UK) or the apparent Tm was calculated as the maximum of the first deriv-
ative of the CD signal with respect to temperature. Both methods of
Tm calculation agreed well. CD spectra were deconvoluted with
the program CDNN (CD neural network, [53]) downloaded from
http://bioinformatik.biochemtech.uni-halle.de/cdnn/index.html.
Supplementary material
Supplementary material including a table of elastolytic fragments of
peptides 1–3 and a table of chemical shift values for peptide 11 at
pH4.0 is available at http://current-biology.com/supmat/supmatin.htm.
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